ライフサイエンスコーパス: pulmonary vein

1 interrogation with monitoring of right upper pulmonary vein.

2 atrial and 6 segments around the ipsilateral pulmonary veins.

3 a3d) is crucial for the normal patterning of pulmonary veins.

4 ause of reconnections in previously isolated pulmonary veins.

5 lungs showed ectatic pulmonary arteries and pulmonary veins.

6 metastases, 3; direct tumor infiltration via pulmonary vein, 1; local relapse of primary sarcoma afte

7 ent AF rotors or focal sources that lay near pulmonary veins (22.8%), left atrial roof (16.0%), and e

8 As a result, 393 pulmonary veins (7 patients with common ostium) were suc

9 r and anterior-inferior segments of the left pulmonary veins (7.2g and 7.9g).

10 isovolumic relaxation time, mitral E/E', and pulmonary vein A wave duration.

11 lar capillary dysplasia with misalignment of pulmonary veins, a lethal congenital disorder, which is

12 ong candidate gene as it is expressed in the pulmonary veins, a source of AF in many individuals.

13 could be identified using a porcine model of pulmonary vein ablation and an extracorporeal circulatio

14 hen performed in addition to circumferential pulmonary vein ablation and linear ablation.

15 phased radiofrequency multielectrode system (pulmonary vein ablation catheter [PVAC], Medtronic, Inc,

16 etected mostly during energy delivery in the pulmonary vein ablation catheter groups, whereas a relat

17 quency pulmonary group 2), and with regime a pulmonary vein ablation catheter with an aggressive anti

18 ocations and connecting them to the existing pulmonary vein ablation lesions was the most effective i

19 prospective Mesh Ablator versus Cryoballoon Pulmonary Vein Ablation of Symptomatic Paroxysmal Atrial

20 Circumferential pulmonary vein ablation was performed followed by roof a

21 re randomized study compared circumferential pulmonary vein ablation+linear ablation (control arm) ve

22 blation (control arm) versus circumferential pulmonary vein ablation+linear ablation+complex fraction

23 onchial fistula as a late complication after pulmonary vein ablation, leading to septic air emboli an

24 During right superior pulmonary vein ablation, the PN was paced at 60 beats pe

25 ho was readmitted to hospital 2 months after pulmonary vein ablation.

26 to medical therapy versus cryoballoon-based pulmonary vein ablation.

27 lar capillary dysplasia with misalignment of pulmonary veins (ACD/MPV), with parent-of-origin effects

28 lar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) is a lethal congenital disorder

29 capillary dysplasia with misalignment of the pulmonary veins, acinar dysplasia, congenital alveolar d

30 ompare the safety and feasibility of durable pulmonary vein and superior vena cava (SVC) isolation be

31 In this chronic porcine study, PFA-based pulmonary vein and SVC isolation were safe and efficacio

32 cterized by progressive obstruction of small pulmonary veins and a dismal prognosis.

33 on characterized by the obstruction of small pulmonary veins and a dismal prognosis.

34 ng persistent AF, limited ablation targeting pulmonary veins and documented nonpulmonary vein trigger

35 nsisted of acute electrical isolation of all pulmonary veins and freedom from recurrent symptomatic a

36 lure (HF) leads to predominate remodeling of pulmonary veins and that the severity of venous remodeli

37 All 4 pulmonary veins and the left atrium posterior wall were

38 atrial structures including the blood pool, pulmonary veins, and mitral valve.

39 Signal intensities around the left and right pulmonary vein antra and along the LA roof and mitral li

40 ess 2 ablation strategies for persistent AF: pulmonary vein antral isolation (PVAI) in sinus rhythm a

41 lar mass index, mitral inflow E/A ratio, and pulmonary vein AR duration were associated with low BDNF

42 ollowed by Bachmann's bundle (N=27, 12%) and pulmonary vein area (N=19, 9%; P<0.001).

43 e, the left atrioventricular groove, and the pulmonary vein area was performed during SR in 381 patie

44 ly ~50% of patients had fibrosis outside the pulmonary vein area).

45 nferior caval, total pulmonary artery, total pulmonary vein, ascending and descending aortic flows (Q

46 days 21 to 35 and major remodeling of small pulmonary veins associated with foci of intense microvas

47 PH was created in Yorkshire swine by partial pulmonary vein banding.

48 ood in early stages, we investigated CTCs in pulmonary vein blood accessed during surgical resection

49 The deep learning model using preablation pulmonary vein computed tomography can be applied to pre

50 Among them, pulmonary vein computed tomography geometric slices from

51 Deep learning was applied to preablation pulmonary vein computed tomography geometric slices to c

52 The accuracy of prediction in each pulmonary vein computed tomography image for NPV trigger

53 Adenosine can unmask dormant pulmonary vein conduction after isolation.

54 ammed electrical stimulation near the murine pulmonary vein demonstrates increased susceptibility to

55 Although treatment strategies including pulmonary vein dilation and stenting have been described

56 hal congenital disorder that occurs when the pulmonary veins do not connect normally to the left atri

57 al strand (MES), the precursor of the common pulmonary vein, does not form at the proper location on

58 ending toward the oval fossa and right upper pulmonary veins draining beyond the cavoatrial junction

59 hich fibrosis underlies the degradation of a pulmonary vein ectopic beat into AF.

60 gling between energy sources, point-by-point pulmonary vein encirclement was performed using biphasic

61 Electrically isolating the pulmonary veins from the left atrium by catheter ablatio

62 capillary dysplasia with misalignment of the pulmonary veins have revealed the causative role of the

63 cing of SEMA3D in individuals with anomalous pulmonary veins identified a phenylalanine-to-leucine su

64 specific symptoms and the need for dedicated pulmonary vein imaging.

65 al left-to-right shunt in 4 and unobstructed pulmonary veins in all patients.

66 f cryotherapy during cryoballoon ablation of pulmonary veins is still unclear.

67 Randomized control trials comparing PWI to pulmonary vein isolation (3 studies, 444 patients) yield

68 Empiric circumferential pulmonary vein isolation (CPVI) has become the therapy o

69 he ablation group were further randomized to pulmonary vein isolation (PVI) (n = 62) or the biatrial

70 ike for paroxysmal atrial fibrillation (AF), pulmonary vein isolation (PVI) alone is considered insuf

71 to compare arrhythmia-free survival between pulmonary vein isolation (PVI) and a stepwise approach (

72 cryoballoon is effective in achieving acute pulmonary vein isolation (PVI) and favorable clinical ou

73 ave been developed to achieve more effective pulmonary vein isolation (PVI) and minimize arrhythmia r

74 es recommend a 3-month blanking period after pulmonary vein isolation (PVI) as early recurrence of at

75 Pulmonary vein isolation (PVI) as interventional treatme

76 nd-generation cryoballoon delivers effective pulmonary vein isolation (PVI) associated with superior

77 can be challenging, often involving not only pulmonary vein isolation (PVI) but also additional linea

78 gate whether the combination of conventional pulmonary vein isolation (PVI) by circumferential antral

79 Pulmonary vein isolation (PVI) for atrial fibrillation i

80 Pulmonary vein isolation (PVI) for persistent atrial fib

81 For the past decade, electric pulmonary vein isolation (PVI) has become a procedure im

82 s the impact of CFAE ablation in addition to pulmonary vein isolation (PVI) in patients undergoing ab

83 Pulmonary vein isolation (PVI) is a recommended treatmen

84 Pulmonary vein isolation (PVI) is an effective treatment

85 Pulmonary vein isolation (PVI) is still associated with

86 It is not known whether complete pulmonary vein isolation (PVI) is superior to incomplete

87 tions include not only the durability of the pulmonary vein isolation (PVI) lines, but also the patho

88 We hypothesized that pulmonary vein isolation (PVI) plus ablation of selectiv

89 Background Although proposed to facilitate pulmonary vein isolation (PVI), high-power ablation may

90 esonance (CMR)-detected atrial fibrosis plus pulmonary vein isolation (PVI).

91 confidence level >7 were ablated followed by pulmonary vein isolation (PVI).

92 ith obstructive sleep apnea (OSA) undergoing pulmonary vein isolation (PVI).

93 AF/AT recurrence is common after pulmonary vein isolation (PVI).

94 Pulmonary vein isolation ablation (n = 79) or previously

95 Following pulmonary vein isolation AF drivers (AFDs) were identifi

96 Patients were randomized to either pulmonary vein isolation alone (n = 148) or pulmonary ve

97 ved in 84 of 148 (56.5%) of those undergoing pulmonary vein isolation alone and in 111 of 154 (72.1%)

98 of VLR in patients who underwent cryoballoon pulmonary vein isolation alone, had an implantable loop

99 ad undergone cardiac surgery exclusively for pulmonary vein isolation and 17 had no structural heart

100 A lower rate of first-pass pulmonary vein isolation and a higher rate of acute pulm

101 During video-assisted thoracoscopic surgical pulmonary vein isolation and CARTO mapping, BrS patients

102 ry, 14 months; Q1-Q3, 7-36 months) underwent pulmonary vein isolation and completed the entire follow

103 l or persistent AF who underwent cryoballoon pulmonary vein isolation and had an implantable loop rec

104 ents with nonparoxysmal AF undergoing antral pulmonary vein isolation and nonpulmonary vein trigger a

105 randomly assigned to (1) standard ablation (pulmonary vein isolation and nonpulmonary vein trigger a

106 rrhythmia recurrences compared with standard pulmonary vein isolation and nonpulmonary vein trigger a

107 CA included pulmonary vein isolation and posterior wall isolation.

108 nt AF and 22 with long-lasting AF, underwent pulmonary vein isolation and substrate modification of c

109 We performed pulmonary vein isolation and voltage mapping in 236 pati

110 Pulmonary vein isolation durability was assessed in 28 v

111 en; 61 long-lasting persistent AF) underwent pulmonary vein isolation followed by electrogram-guided

112 urrence substantially limits the efficacy of pulmonary vein isolation for AF and is associated with p

113 THODS AND Ten consecutive patients underwent pulmonary vein isolation for persistent atrial fibrillat

114 Contact force parameters evaluated during pulmonary vein isolation for treating atrial fibrillatio

115 Although pulmonary vein isolation has become a mainstream therapy

116 Pulmonary vein isolation has increasingly been used to c

117 In humans, variability of CF during pulmonary vein isolation has not been characterized.

118 Procedural strategies beyond pulmonary vein isolation have failed to consistently imp

119 se, Geneva, Switzerland) was used to perform pulmonary vein isolation in 46 patients with paroxysmal

120 lation strategies in the LAAI group included pulmonary vein isolation in 50 (100%), left atrial isthm

121 -13 minutes for STA (P<0.001) with confirmed pulmonary vein isolation in all patients.

122 e targeted for ablation, in conjunction with pulmonary vein isolation in most patients (n=19; 79%).

123 ) and cryoballoon catheter (CB) ablation for pulmonary vein isolation in patients with paroxysmal atr

124 The use of second-generation cryoballoon for pulmonary vein isolation in patients with paroxysmal atr

125 modification in addition to circumferential pulmonary vein isolation irrespective of AF type.

126 Pulmonary vein isolation is an established treatment opt

127 Pulmonary vein isolation is better than antiarrhythmic m

128 its high success and low complication rate, pulmonary vein isolation is expected to be increasingly

129 rial fibrillation (AF) failing to respond to pulmonary vein isolation is important.

130 Pulmonary vein isolation is insufficient to treat all pa

131 Pulmonary vein isolation is the cornerstone of ablation

132 Pulmonary vein isolation is the cornerstone of AF ablati

133 Pulmonary vein isolation is the most prevalent approach

134 Although pulmonary vein isolation of any means/energy source is t

135 n, and (3) The efficacy of PWI compared with pulmonary vein isolation on preventing arrhythmia recurr

136 l fibrillation before electric cardioversion/pulmonary vein isolation or after cardioembolic cerebrov

137 Ablation was performed by circumferential pulmonary vein isolation plus linear ablation of extrapu

138 nd in 111 of 154 (72.1%) of those undergoing pulmonary vein isolation plus renal denervation (hazard

139 pulmonary vein isolation alone (n = 148) or pulmonary vein isolation plus renal denervation (n = 154

140 reablation after a previously failed initial pulmonary vein isolation procedure were eligible for thi

141 s after an apparently successful cryoballoon pulmonary vein isolation procedure.

142 ODS AND We analyzed 42 CF-guided ipsilateral pulmonary vein isolation procedures.

143 CF during pulmonary vein isolation remains highly variable despite

144 e of second-generation 28-mm cryoballoon for pulmonary vein isolation results in an 80% 1-year succes

145 nt this stalemate, safer, and more effective pulmonary vein isolation seems increasingly realistic.

146 The contact force during pulmonary vein isolation should be a target of 10-20 g o

147 icular contractions at the large majority of pulmonary vein isolation sites.

148 ciation between LAPEF and recurrent AF after pulmonary vein isolation that persisted after multivaria

149 uency ablation is the dominant technique and pulmonary vein isolation the principal lesion set.

150 The pulmonary vein isolation therapy duration time (transpir

151 onitoring in the ADVICE (Adenosine Following Pulmonary Vein Isolation to Target Dormant Conduction El

152 on techniques may facilitate safe and simple pulmonary vein isolation to treat paroxysmal atrial fibr

153 Complete pulmonary vein isolation to v an end point of eliminatio

154 aroxysmal AF, planned for first CLOSE-guided pulmonary vein isolation using a contact force radiofreq

155 balloon (LB) with wide-area circumferential pulmonary vein isolation using irrigated radiofrequency

156 imilar efficacy as wide-area circumferential pulmonary vein isolation using irrigated RF in patients

157 tiarrhythmic drug(s), who were scheduled for pulmonary vein isolation using second-generation cryobal

158 ulceration and fistula are complications of pulmonary vein isolation using thermal energy sources.

159 educing AF recurrence, SOE was high favoring pulmonary vein isolation versus antiarrhythmic medicatio

160 Multielectrode pulmonary vein isolation versus single tip wide area cat

161 Pulmonary vein isolation was performed in 94.6% of de no

162 udy included 140 patients (43 women) in whom pulmonary vein isolation was performed using a second-ge

163 l (35 W), whereas in the experimental group, pulmonary vein isolation was performed using high power

164 Pulmonary vein isolation was performed with a cryoballoo

165 Pulmonary vein isolation was the primary ablation approa

166 th paroxysmal atrial fibrillation undergoing pulmonary vein isolation were followed for 12 months wit

167 etic resonance pulmonary vein mapping before pulmonary vein isolation were included.

168 iarrhythmic drugs (class I or III agents) or pulmonary vein isolation with a cryoballoon.

169 Ablation included pulmonary vein isolation with confirmed entrance block a

170 had similar rates of single-procedure acute pulmonary vein isolation without serious adverse events

171 ) and the surgical maze procedure (including pulmonary vein isolation) done during other cardiac surg

172 atients undergoing CF-guided circumferential pulmonary vein isolation, 914 radiofrequency application

173 After 1 year post-pulmonary vein isolation, 93 (49%) patients remained AF

174 After successful pulmonary vein isolation, a bonus freeze was applied.

175 Before pulmonary vein isolation, AF was mapped and then iterati

176 heters have been shown capable of performing pulmonary vein isolation, but not flexible lesion sets s

177 e-shot PFA catheters have been developed for pulmonary vein isolation, but they do not permit flexibl

178 After pulmonary vein isolation, electrogram and spatial inform

179 ablation using a stepwise ablation approach (pulmonary vein isolation, electrogram-guided, and linear

180 -4.3 months) of which 3 had AF terminated on pulmonary vein isolation, leaving 27 patients that under

181 went epicardial thoracoscopic radiofrequency pulmonary vein isolation, linear ablation, Marshal ligam

182 In CF-guided pulmonary vein isolation, PVR is explained by lack of bo

183 ablation at these sites, in conjunction with pulmonary vein isolation, resulted in AF termination or

184 In addition to pulmonary vein isolation, substrate modification and tri

185 Pulmonary vein isolation, with additional ablation proce

186 catheter ablation group (n = 1108) underwent pulmonary vein isolation, with additional ablative proce

187 required spot-ablations to complete electric pulmonary vein isolation.

188 is a novel, nonthermal ablation modality for pulmonary vein isolation.

189 nd may require more extensive treatment than pulmonary vein isolation.

190 Patients with paroxysmal AF underwent pulmonary vein isolation.

191 ed during sinus rhythm in 22 patients before pulmonary vein isolation.

192 before video-assisted thoracoscopic surgical pulmonary vein isolation.

193 paroxysmal AF who were scheduled to undergo pulmonary vein isolation.

194 0 patients; 28%) underwent cryoballoon-based pulmonary vein isolation.

195 ed during sinus rhythm after circumferential pulmonary vein isolation.

196 xation time on CMR and freedom from AF after pulmonary vein isolation.

197 ong association with late recurrent AF after pulmonary vein isolation.

198 All patients underwent successful pulmonary vein isolation.

199 (focal impulse and rotor modulation) before pulmonary vein isolation.

200 AD) therapy in patients with previous failed pulmonary vein isolation.

201 mber of patients with nonparoxysmal AF after pulmonary vein isolation.

202 fibrillation after contact force (CF)-guided pulmonary vein isolation.

203 h a conventional ablation approach was used (pulmonary vein isolation/stepwise approach).

204 fibrillation between patients who underwent pulmonary-vein isolation and those who underwent the bia

205 Current guidelines recommend pulmonary-vein isolation by means of catheter ablation a

206 ion group underwent further randomization to pulmonary-vein isolation or a biatrial maze procedure.

207 o the atrioventricular junction, left atrial pulmonary vein junction, and freewall left ventricle of

208 The pulmonary vein-left atrial (PV-LA) junction is key in pa

209 aintained by localized foci originating from pulmonary vein-left atrium interfaces.

210 Consequently, high rates of pulmonary vein-left atrium reconnections are consistentl

211 s of the crista terminalis/pectinate muscle, pulmonary veins/left atrium.

212 cage ratio at both aortic arch and inferior pulmonary vein level, thoracic cross-sectional area/[hei

213 uperior Pulmonary Vein (LSPV)> Left Inferior Pulmonary Vein (LIPV); p<0.001).

214 onary Vein (RIPV); p=0.001 and Left Superior Pulmonary Vein (LSPV)> Left Inferior Pulmonary Vein (LIP

215 h AF referred for cardiac magnetic resonance pulmonary vein mapping before pulmonary vein isolation w

216 sing sequential recordings from conventional pulmonary vein mapping catheters could achieve similar r

217 al isthmus and anterior segments of the left pulmonary veins may explain why reconnection after ablat

218 A high-density map of LA/pulmonary veins (median 328 sites) was obtained in 18 pa

219 Pulmonary vein narrowing was noted only in the radiofreq

220 Non-pulmonary vein (NPV) trigger has been reported as an imp

221 natomy (volume, AP diameter), anatomy of the pulmonary veins (number, ostia diameters and surface are

222 e of left-to-right interatrial shunt without pulmonary vein occlusion underwent covered stent exclusi

223 t-to-right interatrial shunt without causing pulmonary vein occlusion was confirmed on follow-up imag

224 percutaneous ventricular assist device 5.5%, pulmonary vein or transseptal left atrial cannulation 2.

225 The anatomical assessment of the pulmonary vein ostia and the left atrium size in compute

226 Between-subject variability of the pulmonary vein ostial cross-sectional area and the left

227 ters were significantly larger than the left pulmonary veins ostial diameters (RSPV> LSPV; p<0.001 an

228 The right pulmonary veins ostial diameters were significantly larg

229 cularly in the Bachmann bundle (P=0.008) and pulmonary vein (P=0.020) areas.

230 a3d) mediates endothelial cell repulsion and pulmonary vein patterning during embryogenesis.

231 tion to v an end point of elimination of all pulmonary vein potentials; renal denervation using an ir

232 s initiated when triggered activity from the pulmonary veins propagates into atrial tissue and degrad

233 Rapid pulmonary vein (PV) activity has been shown to maintain

234 Pulmonary vein (PV) and peripheral vein (Pe) blood speci

235 ng activity in the myocardium sleeves of the pulmonary vein (PV) and systemic venous return.

236 We report the outcome of pulmonary vein (PV) antrum isolation in paroxysmal atria

237 Pulmonary vein (PV) antrum isolation in patients with hy

238 Adenosine can unmask dormant pulmonary vein (PV) conduction after PV isolation.

239 ency stimulation identified sites initiating pulmonary vein (PV) ectopy.

240 The anatomic origins of FAT were the right pulmonary vein (PV) in 3 patients, mitral annulus, crist

241 ising new nonthermal ablation technology for pulmonary vein (PV) isolation in patients with atrial fi

242 n catheters have been designed to facilitate pulmonary vein (PV) isolation in patients with paroxysma

243 Atrial fibrillation recurrence after pulmonary vein (PV) isolation is associated with PV to l

244 freedom from atrial fibrillation (AF) after pulmonary vein (PV) isolation using cryoballoon ablation

245 ND ICE trial assessed efficacy and safety of pulmonary vein (PV) isolation using cryoballoon versus r

246 ort-standing persistent atrial fibrillation, pulmonary vein (PV) isolation was performed using the se

247 Acute pulmonary vein (PV) isolation with CB only was achieved

248 was to determine whether PFA allows durable pulmonary vein (PV) isolation without damage to collater

249 Balloon catheters facilitate pulmonary vein (PV) isolation, but current technology is

250 nd clinical performance of this catheter for pulmonary vein (PV) isolation.

251 sed incidence of arrhythmia recurrence after pulmonary vein (PV) isolation.

252 Twenty-six dogs underwent pulmonary vein (PV) isolation.

253 mplication associated with cryoballoon-based pulmonary vein (PV) isolation.

254 chnology designed to achieve single-delivery pulmonary vein (PV) isolation.

255 patient anatomy to achieve acute and durable pulmonary vein (PV) isolation.

256 Thermodynamics in the left atrium-pulmonary vein (PV) junction, phrenic nerve, and esophag

257 Radiofrequency ablation inside pulmonary vein (PV) ostia can cause PV stenosis.

258 ated for paroxysmal atrial fibrillation, the pulmonary vein (PV) reconnection rate is substantial and

259 inent re-entrant driver regions included the pulmonary vein (PV) regions and inferoposterior left atr

260 Pulmonary vein (PV) stenosis is a highly morbid conditio

261 hick tissues relevant to cryoablation of the pulmonary vein (PV).

262 roducibility of anatomical evaluation of the pulmonary veins (PV) and the left atrium (LA) using comp

263 ence of epicardial connections (ECs) between pulmonary veins (PVs) and other anatomic structures may

264 ast rotors in the left atrium (LA) or at the pulmonary veins (PVs) is not fully understood.

265 expressed in cardiomyocytes surrounding the pulmonary veins (PVs), but its contribution to atopic as

266 In 25 patients, acute PVI (96 of 96 pulmonary veins [PVs]; mean ablation time: 22 min; inter

267 equency ablation demonstrated left atrial to pulmonary vein reconduction.

268 s PVI (92% versus 73%; P<0.001), lower acute pulmonary vein reconnection (2% versus 17%; P<0.001), re

269 Pulmonary vein reconnection (PVR) still determines recur

270 vein isolation for AF and is associated with pulmonary vein reconnection and the emergence of new tri

271 ry vein isolation and a higher rate of acute pulmonary vein reconnection were recorded in the group 2

272 ivation sites arising predominantly from the pulmonary vein region.

273 lar capillary dysplasia with misalignment of pulmonary veins remain uncharacterized because of lack o

274 significantly reduces the risk of subsequent pulmonary vein restenosis in comparison with BA.

275 perior Pulmonary Vein (RSPV)> Right Inferior Pulmonary Vein (RIPV); p=0.001 and Left Superior Pulmona

276 eter than the inferior veins (Right Superior Pulmonary Vein (RSPV)> Right Inferior Pulmonary Vein (RI

277 superior vena cava (SVC) and the right upper pulmonary vein (RUPV), which is no longer committed to t

278 tion, mitral E' and E'/A', septal E' and A', pulmonary vein S and D wave velocities, and LV basal glo

279 The frequency of pulmonary vein stenosis (PVS) after ablation for atrial

280 lume index, peak E wave, and the presence of pulmonary vein systolic reversal.

281 There were 298 (83.2%) patients with only pulmonary vein triggers and 60 (16.8%) patients with NPV

282 and 60 (16.8%) patients with NPV triggers+/-pulmonary vein triggers.

283 ncture, sheath flushing, catheter insertion, pulmonary vein venography, and sheath exchange) and 333

284 cases, a second cryoapplication in the same pulmonary vein was safely performed.

285 ver agreement for the detection of accessory pulmonary veins was good (kappa=0.73; 95% CI, 0.54-0.93)

286 Fs during ablation around the right and left pulmonary veins were 22.8g (12.6-37.9; q1-q3) and 12.3g

287 Pulmonary veins were assessed for PAPVR or TAPVR, PDA, c

288 Outcomes were better if the pulmonary veins were encircled (OR, 0.26; 95% CI, 0.09-0

289 Accessory pulmonary veins were found in 24% of patients.

290 A total of 192 pulmonary veins were identified, and 191 of 192 (99%) pu

291 All pulmonary veins were isolated in both groups.

292 All pulmonary veins were isolated without steam pop, impedan

293 All target pulmonary veins were isolated.

294 Ablations of the pulmonary veins were performed in 18 swine with echo mon

295 veins were identified, and 191 of 192 (99%) pulmonary veins were successfully isolated.

296 s initiated by applied ectopic pacing in the pulmonary veins, which led to the generation of localize

297 nal MIL design, connecting the left inferior pulmonary vein with the mitral annulus.

298 rategy is likely to combine isolation of the pulmonary veins with limited linear ablation within the

299 ates the anatomy of the left atrium (LA) and pulmonary veins with significant differences between the

300 ateral MIL design, connecting the left-sided pulmonary veins with the mitral annulus along the poster